Content area
Full text
A study funded by the U.S. Army Medical Research and Materiel Command is the first of its kind to use a pharmaceutical-grade, antiplaque chewing gum in humans to test the feasibility of delivering a drug through chewing gum.
The compound, developed by the Dental and Trauma Research Detachment (DTRD) at the U.S. Army Institute of Surgical Research at Joint Base San AntonioFort Sam Houston, Texas, is known as KSL-W.
...





